. Author manuscript; available in PMC: 2021 Nov 1.

Published in final edited form as: Nat Rev Cancer. 2021 Mar 23;21(5):281–297. doi: 10.1038/s41568-021-00344-2

Table 2 |.

Ongoing clinical trials of combinations with immunotherapy

Tumour type	Clinical trial phase	Treatment	Clinical trial identification number
Metastatic RCC	I/II	HCQ/aldesleukin (IL-2)	NCT01550367
Metastatic melanoma	I/II	HCQ/nivolumab HCQ/nivolumab/Ipilimumab	NCT04464759
Gastrointestinal cancer	I/II	HCQ/cobimetinib/atezolizumab	NCT04214418
Pancreatic cancer	II	HCQ/gemcitabine/nab-paclitaxel/avelumab	NCT03344172

Data are collected from US National Library of Medicine ClinicalTrials.gov. HCQ, hydroxychloroquine; RCC, renal cell carcinoma.